IL140164A0 - Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug - Google Patents

Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Info

Publication number
IL140164A0
IL140164A0 IL14016400A IL14016400A IL140164A0 IL 140164 A0 IL140164 A0 IL 140164A0 IL 14016400 A IL14016400 A IL 14016400A IL 14016400 A IL14016400 A IL 14016400A IL 140164 A0 IL140164 A0 IL 140164A0
Authority
IL
Israel
Prior art keywords
carnitine
drug
containing composition
dietary supplement
composition useful
Prior art date
Application number
IL14016400A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of IL140164A0 publication Critical patent/IL140164A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IL14016400A 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug IL140164A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number Publication Date
IL140164A0 true IL140164A0 (en) 2002-02-10

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14016400A IL140164A0 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Country Status (26)

Country Link
US (1) US6565876B1 (es)
EP (1) EP1119363B1 (es)
JP (1) JP2002542282A (es)
KR (1) KR20010053023A (es)
CN (1) CN1359295A (es)
AR (1) AR023391A1 (es)
AT (1) ATE299370T1 (es)
AU (1) AU776591B2 (es)
BR (1) BR0006076A (es)
CA (1) CA2335015C (es)
DE (1) DE60021247T2 (es)
DK (1) DK1119363T3 (es)
EE (1) EE200000742A (es)
ES (1) ES2243254T3 (es)
HU (1) HU227357B1 (es)
IL (1) IL140164A0 (es)
IS (1) IS5763A (es)
IT (1) IT1306133B1 (es)
NO (1) NO20006429L (es)
PL (1) PL197885B1 (es)
PT (1) PT1119363E (es)
SI (1) SI1119363T1 (es)
SK (1) SK19322000A3 (es)
TN (1) TNSN00083A1 (es)
TR (1) TR200003737T1 (es)
WO (1) WO2000064426A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
DK1863495T3 (en) * 2005-03-18 2015-04-20 Normoxys Inc CALCIUM AND SODIUM SALT OF MYO-INOSITOL 1.6: 2,3: 4,5 TRIPYROPHOSPHATE FOR CANCER TREATMENT
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
WO2010054978A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
EP2582368B1 (en) 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
CN114144493A (zh) * 2019-05-23 2022-03-04 Ekyj Ii 咨询有限责任公司 治疗和减轻酒精诱导的皮肤潮红的组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
WO2000064426A2 (en) 2000-11-02
WO2000064426A3 (en) 2001-05-25
PL197885B1 (pl) 2008-05-30
PT1119363E (pt) 2005-09-30
DE60021247D1 (de) 2005-08-18
KR20010053023A (ko) 2001-06-25
EE200000742A (et) 2002-04-15
CA2335015C (en) 2008-03-18
EP1119363B1 (en) 2005-07-13
ES2243254T3 (es) 2005-12-01
AR023391A1 (es) 2002-09-04
ITRM990248A1 (it) 2000-10-22
TNSN00083A1 (fr) 2005-11-10
JP2002542282A (ja) 2002-12-10
ATE299370T1 (de) 2005-07-15
NO20006429D0 (no) 2000-12-15
US6565876B1 (en) 2003-05-20
DK1119363T3 (da) 2005-10-17
HU227357B1 (en) 2011-04-28
CN1359295A (zh) 2002-07-17
CA2335015A1 (en) 2000-11-02
HUP0102926A2 (hu) 2002-03-28
PL346160A1 (en) 2002-01-28
SK19322000A3 (sk) 2001-06-11
EP1119363A2 (en) 2001-08-01
IT1306133B1 (it) 2001-05-30
HUP0102926A3 (en) 2002-12-28
SI1119363T1 (en) 2005-10-31
NO20006429L (no) 2001-02-20
TR200003737T1 (tr) 2001-07-23
DE60021247T2 (de) 2006-04-27
AU4313500A (en) 2000-11-10
BR0006076A (pt) 2001-03-20
AU776591B2 (en) 2004-09-16
IS5763A (is) 2000-12-08

Similar Documents

Publication Publication Date Title
GB9916536D0 (en) Nutritional or pharmaceutical compositions
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HK1048066A1 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
PL343627A1 (en) Medicinal compositions
HUP0102926A3 (en) Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
GB2354153B (en) Dietary supplement
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
GB9920054D0 (en) Dietary composition
HUP0201443A2 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them
IL133851A0 (en) Dietary supplement
IL122883A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
EP1235806A4 (en) NEW 5-PYRIMIDINE CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL MIXTURES CONTAINING THESE DERIVATIVES